STAA News

STAAR Surgical to Host Fourth Quarter and Fiscal Year 2025 Earnings Conference Call and Webcast on March 3, 2026

FDA Expands U.S. Age Indication for EVO ICL as Long-Term Safety Data Reinforces Market Shift Away From Laser Vision Correction

FDA Expands U.S. Age Indication for EVO ICL as Long-Term Safety Data Reinforces Market Shift Away From Laser Vision Correction

STAAR Surgical Appoints Warren Foust and Deborah Andrews Interim Co-CEOs

STAAR Surgical and Broadwood Partners Enter Into Cooperation Agreement

Alcon Terminates Agreement to Acquire STAAR Surgical

Alcon Terminates Agreement to Acquire STAAR Surgical

Broadwood Partners Comments on STAAR Surgical Shareholders’ Rejection of the Company’s Proposed Sale to Alcon

STAAR Surgical Announces Preliminary Results of Special Meeting of Stockholders

Broadwood Partners Denounces STAAR Surgical’s Fourth Delay of the Shareholder Vote on the Company’s Proposed Sale to Alcon